MK 801: A Possible Neuroprotective Agent by Poststroke Depression?
To the Editor: Stroke is the third leading cause of death and adult morbidity in developed countries. 1 Many deleterious cellular pathways have been proposed to explain the molecular pathogenesis of this clinically devastating disease. 2 Interest in the role of neurotransmitters in the pathogenesis of ischemic stroke resulted in studies establishing that the release of glutamate and its excitotoxic actions through the N -methyl- D -aspartic acid (NMDA) receptors are significant in the development of ischemic neuronal damage. 2
It is widely known that the occurrence of poststroke mood disorders, especially depression, is one of the most frequent complications of stroke. 3 It affects approximately 20% to 40% of all patients and the definitive treatment includes various antidepressant agents. 3 Interestingly, the evidence regarding antidepressant activity of NMDA receptor antagonists (especially MK 801) is rapidly replicating. 4 , 5 In light of these findings, we wanted to evaluate whether this novel antidepressant agent also has a neuroprotective effect by cerebral ischemia.
To examine this matter, we evaluated the neuroprotective effect of MK 801 (dizocilpine), a noncompetitive NMDA receptor antagonist, after transient focal cerebral ischemia, a relevant model for the thrombolyzed stroke in humans.
Anesthetized Wistar rats (330–370 g) were submitted to transient thread occlusion of the middle cerebral artery using an intraluminal filament technique. 6 The rectal temperature was maintained between 36.5°C and 37.0°C using a feedback-controlled heating system. The cerebral blood flow, measured by laser Doppler flowmetry, was reduced to ∼15% of preischemic control levels immediately after thread insertion in all animal groups. MK 801 or vehicle was applied intraperitoneally (3 mg/kg) just after transient ischemia. Twenty-four hours after reperfusion, the area of infarction was measured by toluidine blue staining. This study was interesting with regard to poststroke depression by which a mood stabilizer with neuroprotective properties would be preferable.
MK 801 showed a significant neuroprotection (p<0.05, analysis of variance followed by least significant difference tests) after transient focal cerebral ischemia (73.12±23.2 versus 23.12+21.1) ( Figure 1 ). In summary, this study indicates that even with a serious brain injury, MK 801 could exert a significant neuroprotective effect. However, further experiments to evaluate the long-term clinical reflections of such neuroprotective effects of MK 801 in poststroke depression patients via MRI and spectroscopy studies, would be logical future steps in the field of psychiatric research.
![](/cms/10.1176/jnp.2008.20.3.367/asset/images/medium/ak0121f1.jpeg)
Data are given as means±SD
Animals treated with MK 801 (3 mg/kg) led to a decrease in infarct size.
*Significantly different from vehicle-treated control animals (p≤0.05).
The first two authors contributed equally to this work.
1 . Rothwell PM: The high cost of nonfunding stroke research: a comparison with heart disease and cancer. Lancet 2001; 357:1612–1616.Google Scholar
2 . Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 1999; 22:391–397Google Scholar
3 . Whyte EM, Mulsant BH: Poststroke depression: epidemiology, pathophysiology and biological treatment. Biol Psychiatry 2002; 52:253–264Google Scholar
4 . Zomkowski AD, Hammes L, Lin J, et al: Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002; 25:387–391Google Scholar
5 . Chaturvedi HK, Bapna JS, Chandra D: Effect of fluvoxamine and N -methyl- D -aspartate receptor antagonists on shock-induced depression in mice. Indian J Physiol Pharmacol 2001; 45:199–207. Google Scholar
6 . Koizumi J, Yoshida Y, Nakazawa T, et al: Experimental studies of ischemic brain edema. Part I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8:1–8 (Japanese)Google Scholar